282 related articles for article (PubMed ID: 36641292)
1. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.
Wei J; Jiang H; Zhou Y; Tian J; Furtado FS; Catalano OA
Dig Liver Dis; 2023 Jul; 55(7):833-847. PubMed ID: 36641292
[TBL] [Abstract][Full Text] [Related]
2. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma.
Bo Z; Song J; He Q; Chen B; Chen Z; Xie X; Shu D; Chen K; Wang Y; Chen G
Comput Biol Med; 2024 May; 173():108337. PubMed ID: 38547656
[TBL] [Abstract][Full Text] [Related]
3. Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities.
Yang WS; Jiang HY; Liu C; Wei JW; Zhou Y; Gong PY; Song B; Tian J
Chin Med Sci J; 2021 Sep; 36(3):173-186. PubMed ID: 34666870
[TBL] [Abstract][Full Text] [Related]
4. MRI-Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges.
Xia T; Zhao B; Li B; Lei Y; Song Y; Wang Y; Tang T; Ju S
J Magn Reson Imaging; 2024 Mar; 59(3):767-783. PubMed ID: 37647155
[TBL] [Abstract][Full Text] [Related]
5. Radiomics in Hepatocellular Carcinoma.
Sagir Kahraman A
J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
[TBL] [Abstract][Full Text] [Related]
6. Current status and future perspectives of radiomics in hepatocellular carcinoma.
Miranda J; Horvat N; Fonseca GM; Araujo-Filho JAB; Fernandes MC; Charbel C; Chakraborty J; Coelho FF; Nomura CH; Herman P
World J Gastroenterol; 2023 Jan; 29(1):43-60. PubMed ID: 36683711
[TBL] [Abstract][Full Text] [Related]
7. Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives.
Feng B; Ma XH; Wang S; Cai W; Liu XB; Zhao XM
World J Gastroenterol; 2021 Aug; 27(32):5341-5350. PubMed ID: 34539136
[TBL] [Abstract][Full Text] [Related]
8. [Research progress of radiomics with artificial intelligence in precise diagnosis and treatment of hepatocellular carcinoma].
Li YH; Jia WD
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):905-909. PubMed ID: 33256273
[TBL] [Abstract][Full Text] [Related]
9. Toward Personalized Medicine in Radiotherapy of Hepatocellular Carcinoma: Emerging Radiomic Biomarker Candidates of Response and Toxicity.
De la Pinta C
OMICS; 2021 Sep; 25(9):537-544. PubMed ID: 34448625
[TBL] [Abstract][Full Text] [Related]
10. Radiomics in the diagnosis and treatment of hepatocellular carcinoma.
Jiang C; Cai YQ; Yang JJ; Ma CY; Chen JX; Huang L; Xiang Z; Wu J
Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):346-351. PubMed ID: 37019775
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.
Aquino IMC; Pascut D
Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709
[TBL] [Abstract][Full Text] [Related]
12. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
13. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
15. Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics.
Liu P; Tan XZ; Zhang T; Gu QB; Mao XH; Li YC; He YQ
World J Gastroenterol; 2021 May; 27(17):2015-2024. PubMed ID: 34007136
[TBL] [Abstract][Full Text] [Related]
16. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art in radiomics of hepatocellular carcinoma: a review of basic principles, applications, and limitations.
Miranda Magalhaes Santos JM; Clemente Oliveira B; Araujo-Filho JAB; Assuncao-Jr AN; de M Machado FA; Carlos Tavares Rocha C; Horvat JV; Menezes MR; Horvat N
Abdom Radiol (NY); 2020 Feb; 45(2):342-353. PubMed ID: 31707435
[TBL] [Abstract][Full Text] [Related]
18. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence-based radiomics in bone tumors: Technical advances and clinical application.
Meng Y; Yang Y; Hu M; Zhang Z; Zhou X
Semin Cancer Biol; 2023 Oct; 95():75-87. PubMed ID: 37499847
[TBL] [Abstract][Full Text] [Related]
20. Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response.
Borhani AA; Catania R; Velichko YS; Hectors S; Taouli B; Lewis S
Abdom Radiol (NY); 2021 Aug; 46(8):3674-3685. PubMed ID: 33891149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
